ArticleJournal of the American Chemical Society2010

Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design.

Christopher T Veldkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.